Noom Bundles New Band Into Enterprise Weight Programs
Noom announced Noom Band at HLTH USA 2026 in Las Vegas on Monday, November 16, 2026. The faceless wrist wearable, powered by Sensor Bio, tracks heart rate, heart rate variability, blood oxygen, sleep and activity, and it will be included for all Noom Health employer and health plan clients in 2027 at no additional up-front cost to the payer. Noom's headline claim — wearable users 34 percent more likely to lose 20 pounds — counts any connected wearable, not the band, which hasn't shipped.
Edited and fact-checked by Stephen Sprague
The band ships inside employer and health plan contracts in 2027. What Noom hasn't published is what members pay, how long the battery lasts, or what happens to the data when a program ends.
Noom announced its first wearable, Noom Band, on Monday, November 16, 2026, at HLTH USA 2026 in Las Vegas, and it's giving the device away inside its existing deals. The band will be included for all Noom Health employer and health plan clients in 2027 at no additional up-front cost to the payer, the company said. It's a faceless wrist-worn wearable, built on Sensor Bio's sensing platform, and it feeds heart rate, heart rate variability, blood oxygen, sleep and activity data straight into Noom's behavior-change programs.
The mechanics are the story. Noom sells metabolic health programs to employers and health plans — Noom Med and its other clinical programs, Noom Weight, Noom Diabetes and the Diabetes Prevention Program — and it's paid, in part, on outcomes. Chief executive Geoff Cook told Fierce Healthcare the company is getting outcomes-based payments and believes more members will hit their 5 percent and 10 percent weight-loss goals with the wearable than without it. A free band, on that contract structure, isn't a gift. It's the payer's measurement instrument, worn on the member's wrist, and Noom is betting the data pays for the hardware.
The sensor package comes from Sensor Bio, an Austin, Texas company that supplies wearable sensors and a raw-data platform to research and enterprise health programs. Noom controls how the signals are interpreted and folded into its coaching and clinical interventions; Sensor Bio supplies the validated sensing underneath. The band is designed, Noom said, to capture measurements tied to weight management and metabolic health rather than athletic performance — continuous signals, collected whether or not the member opens the app, logged a meal or stepped on a scale.
The launch carries one headline number, and it needs its conditions attached. Noom says members taking GLP-1 weight-loss drugs who used a connected wearable were 34 percent more likely to lose 20 pounds by month four than members who didn't. That's a relative figure, and the release doesn't give the absolute share of either group that reached 20 pounds, so the size of the gap in real terms isn't stated. The analysis covers 144,593 Noom Med users who signed up between September 16, 2025, and July 8, 2026, met engagement criteria including at least two weight measurements, and connected a device in month one. Median starting body mass index was 30.0 for the wearable group and 29.4 for the rest. The data haven't been peer-reviewed.
One more condition matters more than the rest: the 34 percent figure counts any connected wearable. It doesn't measure Noom Band, which hasn't shipped. Members in the analysis were wearing other companies' devices. The claim, read precisely, is that Noom members who track themselves with a wearable do better than members who don't — a finding that could reflect the kind of member who connects a device in the first month as much as the device itself. Noom Band's job is to make sure the device on the wrist is Noom's, and that the data lands in Noom's platform instead of a competitor's.
What the release doesn't disclose is a longer list than what it does. There's no retail price, because there may never be one. There's no statement of what members themselves pay, if anything. There's no battery life, no screen or water-resistance specification beyond the faceless design, and no terms specific to how band data is stored, shared or deleted — a live question for a device that streams heart, sleep and oxygen data from employees to a platform their employer pays for. Noom also plans to test the model in public: it intends to participate in the Centers for Medicare and Medicaid Services' ACCESS model for chronic care, under the cardio-kidney-metabolic track covering obesity, prediabetes and diabetes.
The band is on display at Noom's booth at HLTH USA 2026, which runs November 15 to 18 at The Venetian Expo in Las Vegas. It reaches members in 2027, bundled into contracts their employers and health plans already hold. The questions that decide whether it works aren't the sensor questions — heart rate and sleep tracking are solved problems. They're the contract questions: whether outcomes-based payment actually moves when a band is on the wrist, and what happens to a continuous record of a worker's body once the program ends. Noom has answered the first with its own unreviewed numbers. The second it hasn't answered at all.
The conversation.
Loading comments…
A little more perspective.
Reading is free. Verified members can comment and reply for $2 a month.